H Mesquita Gabriel

Summary

Country: Portugal

Publications

  1. ncbi Role of abciximab in the treatment of coronary artery disease
    H Mesquita Gabriel
    Unidade de Cardiologia de Intervenção Joaquim Oliveira, Servico de Cardiologia, Hospital de Santa Maria, Avenida Egas Moniz, 1649 035 Lisboa, Portugal
    Expert Opin Biol Ther 6:935-42. 2006
  2. ncbi Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial
    H Mesquita Gabriel
    Servico de Cardiologia, Hospital de Santa Maria, Lisbon, Portugal
    Catheter Cardiovasc Interv 68:218-24. 2006

Detail Information

Publications2

  1. ncbi Role of abciximab in the treatment of coronary artery disease
    H Mesquita Gabriel
    Unidade de Cardiologia de Intervenção Joaquim Oliveira, Servico de Cardiologia, Hospital de Santa Maria, Avenida Egas Moniz, 1649 035 Lisboa, Portugal
    Expert Opin Biol Ther 6:935-42. 2006
    ..It is used for treatment of coronary artery disease, being well-studied in the setting of acute coronary syndromes and percutaneous coronary intervention, in which a rapid and effective antiaggregation is clinically important...
  2. ncbi Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial
    H Mesquita Gabriel
    Servico de Cardiologia, Hospital de Santa Maria, Lisbon, Portugal
    Catheter Cardiovasc Interv 68:218-24. 2006
    ..We assessed the safety and efficacy of early administration of abciximab prior to percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients...